Sitero, a technology-enabled Clinical Research Organization (CRO), announces it has acquired the AI assets and business of studyOS – a novel eClinical AI technology provider and creator of Ash – the AI Clinical Trial Agent. The transaction marks another milestone in Sitero’s mission to deeply integrate advanced technology with operational excellence across the clinical development spectrum. The acquisition reinforces Sitero’s strategy to combine innovative, regulation-ready AI solutions with best-in-class service delivery—creating a unified environment where automation, analytics, and oversight converge to improve speed, quality and compliance in global clinical trials.
Read the full article: Sitero Acquires StudyOS and Launches SiteroAI, Becoming the Industry’s First Truly AI-Powered CRO //
Source: https://www.prnewswire.com/news-releases/sitero-acquires-studyos-and-launches-siteroai-becoming-the-industrys-first-truly-ai-powered-cro-302602066.html